医学
肺结核
外科
安慰剂
内科学
病理
替代医学
作者
А. К. Иванов,Т. В. Сологуб,А. М. Пантелеев,Дмитрий Сергеевич Суханов,М. Г. Романцов,А. Л. Коваленко
出处
期刊:Экспериментальная и клиническая фармакология
日期:2010-03-23
卷期号:73 (7): 32-35
标识
DOI:10.30906/0869-2092-2010-73-7-32-35
摘要
Outcome of treatment of 102 patients co-infected with HIV and tuberculosis hospitalized at Second Municipal Tuberculosis Hospital (St. Petersburg) is analyzed. The median period of follow up was 8 weeks. In order to select the optimum treatment scheme, all patients were divided into three groups (I - III). Group I (51 patients) received, in addition to antituberculosis medications, cycloferon 600 mg tablets on alternate days. Group II (16 patients) received alpha and gamma interferons (Interal injection, 3 MU and Ingaron injection, 500,000 on alternate days) in combination with antituberculosis medications. Control group III (35 patients) received antituberculosis treatment plus placebo. Assessment of the outcome of TB treatment upon 8 weeks of follow up showed a remarkable improvement of clinical and immunological conditions in the patients who received interferons and cycloferon.
科研通智能强力驱动
Strongly Powered by AbleSci AI